A CONTROLLED STUDY OF ORAL PREDNISOLONE IN FROZEN SHOULDER

Rheumatology ◽  
1986 ◽  
Vol 25 (3) ◽  
pp. 288-292 ◽  
Author(s):  
A. BINDER ◽  
B. L. HAZLEMAN ◽  
G. PARR ◽  
S. ROBERTS
Keyword(s):  
Frozen Shoulder ◽  
Oral Prednisolone ◽  
Controlled Study

scholarly journals Oral prednisolone for acute otitis media in children: protocol of a pilot randomised, open-label, controlled study (OPAL study)

2018 ◽  
Vol 4 (1) ◽  
Author(s):  
Respati W. Ranakusuma ◽  
Amanda R. McCullough ◽  
Eka D. Safitri ◽  
Yupitri Pitoyo ◽  
Widyaningsih ◽  
...  
Keyword(s):  
Otitis Media ◽  
Acute Otitis Media ◽  
Oral Prednisolone ◽  
Controlled Study ◽  
Open Label

scholarly journals AB1310-HPR EFFECTS OF INSTRUMENT-ASSISTED SOFT TISSUE MOBILIZATION ON FROZEN SHOULDER: A RANDOMIZED CONTROLLED TRIAL

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1945.2-1945
Author(s):  
E. Kaya Mutlu ◽  
T. Birinci ◽  
S. Kilic
Keyword(s):  
Soft Tissue ◽  
Range Of Motion ◽  
Frozen Shoulder ◽  
Controlled Study ◽  
Joint Mobilization ◽  
Randomized Controlled ◽  
Constant Murley Score ◽  
Group I ◽  
Group Ii ◽  
Soft Tissue Mobilization

Background:Frozen shoulder has a greater incidence, more severe course, and resistance to treatment in patients. Management is based on the underlying cause of pain and stiffness. Joint mobilization has been reported to improve joint range of motion in frozen shoulder. However, there is no information regarding the effect of instrument-assisted soft tissue mobilization (IASTM) in frozen shoulder. We proposed that there would be no significant difference between the two manual physical therapy techniques with relatively similar treatment effects in the frozen shoulder.Objectives:The aim of this randomized controlled study was to compare the effectiveness of IASTM and joint mobilization in the treatment of patients with frozen shoulder.Methods:Thirty patients with phase II frozen shoulder (mean age 50,9 years, age range 39–65 years) were randomly assigned to one of the two treatment groups: Group I received joint mobilization combined with manual stretching exercise and Group II received IASTM with manual stretching exercise (two days per week for six weeks) (Figure 1). The pain level was evaluated with a visual analogue scale (VAS) and the active range of motion (ROM) was measured with a universal goniometer. The Disabilities of the Arm, Shoulder and Hand score and the Constant-Murley score were used for functional assessment. The assessments were performed at baseline and after the 6-week intervention.Figure 1.Instrument-Assisted Soft Tissue MobilizationResults:Both groups had a significant decrease in pain according to VAS and a significant increase in ROM and function level (p<0.05). After the 6-week intervention, improvement of shoulder abduction ROM in Group I was found significantly higher than Group II (p=0.01), on the other hand, Constant-Murley score in Group II was found significantly higher compared to Group I (p=0,001).Conclusion:Our results supported the hypothesis that either joint mobilization or IASTM, performed in addition to stretching exercise, provided similar improvements in pain levels in patients with the frozen shoulder.References:[1]Kelley MJ, Shaffer MA, Kuhn JE, Michener LA, Seitz AL, Uhl TL, et al. Shoulder Pain and Mobility Deficits: Adhesive Capsulitis, J Orthop Sports Phys Ther, 2013:43:1-31.[2]Celik D, Kaya Mutlu E.Does AddingMobilization toStretchingImprove Outcomes for People with Frozen Shoulder? A Randomized Controlled Clinical Trial, Clin Rehab, 2016: 30(8): 786-794.[3]Iked N, Otsuka S, Kawanishi Y, Kawakami Y. Effects of Instrument-Assisted Soft Tissue Mobilization on Musculoskeletal Properties, Med Sci Sports Exerc, 2019:51(10): 2166-2172.Disclosure of Interests:None declared

Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL

2009 ◽  
Vol 141 (5) ◽  
pp. 579-583 ◽  
Author(s):  
Seok Min Hong ◽  
Chan Hum Park ◽  
Jun Ho Lee
Keyword(s):  
Treatment Modality ◽  
Oral Prednisolone ◽  
Primary Treatment ◽  
Oral Steroid ◽  
Controlled Study ◽  
Low Frequencies ◽  
Tertiary Referral Center ◽  
Primary Treatment Modality ◽  
Oral Group ◽  
Hearing Outcomes

Objective: Intratympanic (IT) dexamethasone offers a good method for avoiding systemic side effects in patients with sudden idiopathic sensorineural hearing loss (ISSHL). However, in most studies, IT was used as a salvage treatment for patients whose hearing failed to improve with the initial systemic treatment, or as an addition to conventional oral steroid protocols. Therefore, we investigated the outcomes of IT steroid administration as a primary treatment modality for ISSHL. Study Design: Randomized controlled study. Setting: Tertiary referral center. Subjects and Methods: Two treatment methods, IT dexamethasone or oral prednisolone, were randomly assigned to 63 participants. A group of 32 patients (IT group) with ISSHL received IT dexamethasone once a day for eight days. A separate group of 31 patients (oral group), received oral prednisolone, also for eight days. We compared the hearing outcomes in the two groups. Results: We have found that the outcomes for patients treated with IT dexamethasone as a primary treatment modality for the management of ISSHL presented no difference in pure-tone averages or hearing recovery rate compared with patients treated with oral steroids. However, differences were noted for hearing thresholds according to frequency: the threshold improvement at low frequencies (250, 500, and 1000 Hz) was not statistically significant between groups; at high frequencies, particularly 4000 and 8000 Hz, the threshold improvement was statistically higher in the oral group than in the IT group. Conclusion: IT dexamethasone might be a good primary treatment method for ISSHL; but, for the management of ISSHL, we should keep in mind the differences in hearing outcomes with regard to frequency.

scholarly journals High-dose short-course oral corticosteroid protocol for treatment of primary frozen shoulder: a retrospective cohort study

2021 ◽  
Vol 49 (7) ◽  
pp. 030006052110248
Author(s):  
Teoman Atici ◽  
Cenk Ermutlu ◽  
Selcan Akesen ◽  
Ali Özyalçin
Keyword(s):  
Early Stage ◽  
Frozen Shoulder ◽  
Early Period ◽  
Oral Prednisolone ◽  
Rapid Recovery ◽  
Drug Discontinuation ◽  
High Dose ◽  
Dash Score ◽  
Constant Murley Score ◽  
Shoulder Motion

Objective To evaluate the effect of high-dose prednisolone on the functional outcome of patients with early-stage primary frozen shoulder. Methods Eighteen patients treated with oral prednisolone at an initial dose of 1 mg/kg/day for primary frozen shoulder were retrospectively evaluated. The patients’ range of motion, Disabilities of the Arm, Shoulder, and Hand (DASH) score, Constant–Murley score, American Shoulder and Elbow Surgeons (ASES) score, and visual analog scale score were recorded at baseline and at 4 weeks and 6 months after treatment. Results Rapid recovery of shoulder motion was noted at 4 weeks with the exception of abduction, which was maintained at 6 months. Significant improvement in pain perception and the Constant–Murley score was evident at 4 weeks and extended to 6 months. The DASH and ASES scores did not show significant improvement in the first 4 weeks but were significantly improved at 6 months. Conclusion High-dose oral prednisolone treatment provides rapid symptom resolution that persists long after drug discontinuation. The early treatment period is characterized by marked reduction in pain and rapid recovery of shoulder motion. Improvements in functional outcomes and disability indices tend to be more subtle in the early period but significantly improve during late treatment.

Sign in / Sign up

Export Citation Format

Share Document